HOME >> MEDICINE >> NEWS
NPSF workshop builds community to improve pharmaceutical safety

Chicago, IL - On June 10-11, 1999, the National Patient Safety Foundation (NPSF) will convene a workshop in Washington, DC to design and build consensus around a collaborative action plan to promote pharmaceutical safety. Fifty opinion leaders will participate, representing five key stakeholder groups that can make a difference - the FDA & Government, Medicine & Health Care Practitioners, Pharmacists, Patients & Public Interest Groups, and the Pharmaceutical Industry.

"Each of these groups is working to assure pharmaceutical safety every day. But until all stakeholders in the pharmaceutical safety chain begin to align our strategies and work collaboratively, our efforts will not reach their full potential to maximize benefit and reduce risk and harm to patients," says Eleanor Vogt, RPh, PhD, Senior Fellow of the NPSF. "This workshop provides a neutral forum to leverage the discussion about underlying issues that keep the community from working together to advance safety."

Expected outcomes of this workshop include a collaborative action plan to be released this summer for a pharmaceutical safety initiative. The plan will incorporate the group consensus on the strengths and vulnerabilities of the system, the roles and responsibilities of the major players in the pharmaceutical chain, the existing tools and resources, and the gaps that need to be filled to responsibly address medication safety issues. It will serve as an action agenda for the work of the community as well as the NPSF.

This project is made possible by a public/private partnership reflected in a major grant from Pfizer Inc with additional support from Bristol-Myers Squibb Research Institute, CVS Drug Stores, DuPont Pharmaceuticals Company, the US Food and Drug Administration, the Warner-Lambert company and Janssen Pharmaceutica.

Founded in 1997 by the American Medical Association, CNA HealthPro, 3M, and other partners, the National Patient Safety Foundation is an independent, nonpro
'"/>

Contact: Susan Wagner
susan_wagner@ama-assn.org
312-464-5418
National Patient Safety Foundation
9-Jun-1999


Page: 1 2

Related medicine news :

1. NIH convenes workshop on menopausal hormone therapy
2. Hands-on cancer biology workshop for journalists
3. AAPS kicks off new century with workshop on bioanalytical methods validation
4. PQRI workshop to address blend uniformity
5. AAPS workshop to explore regulatory approaches to bioavailability, bioequivalence
6. AAPS workshop to examine changes in analytical methods and packaging
7. AAPS workshop to explore pharmaceutical reference standards
8. AAPS presents workshop on macromolecules
9. Exercise therapy builds strength, mobility in MS patients
10. Success of experimental herpes vaccine builds momentum for human clinical trials
11. Privacy rule builds biomedical research bottleneck

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: NPSF workshop builds community improve pharmaceutical safety

(Date:10/31/2014)... BCC Research ( http://www.bccresearch.com ) reveals in its ... the U.S. indoor air quality (IAQ) market is expected to ... growth rate (CAGR) of 7% over the next five years. ... CAGR of 7.4%. , Since 2012, continuing media attention ... of infectious diseases such as bird flu and the increase ...
(Date:10/31/2014)... Boca Raton, FL (PRWEB) October 31, 2014 ... wellness company founded on the highest principles of patient ... Lifescript , a leading health and wellness website, to ... those living with diabetes. , The Diabetes Health ... tips and recipes for those living with diabetes. Content ...
(Date:10/31/2014)... News) -- Carving pumpkins and trick-or-treating may seem like ... emergency rooms in the United States every year, experts ... fifth highest number of ER visits involving children aged ... the National Electronic Injury Surveillance System. Nearly ... the American Academy of Orthopaedic Surgeons and the Pediatric ...
(Date:10/31/2014)... to generic hormone therapy medicines improves the chances that ... a new study found. "We know that hormone ... reduce recurrence by up to 50 percent," study leader ... Columbia University Medical Center in New York City, said ... by our group and others has shown that a ...
(Date:10/31/2014)... News) -- There are clear differences in the brains ... of healthy people, new research indicates. Scientists ... could help doctors diagnose this baffling condition and shed ... syndrome are often misdiagnosed or labeled as hypochondriacs. ... "we found that [chronic fatigue syndrome] patients, brains diverge ...
Breaking Medicine News(10 mins):Health News:Global Market for U.S. Indoor Air Quality (IAQ) to Reach $11.4 Billion by 2019; Equipment Market Segment Surging at 7.4% CAGR 2Health News:Global Market for U.S. Indoor Air Quality (IAQ) to Reach $11.4 Billion by 2019; Equipment Market Segment Surging at 7.4% CAGR 3Health News:Med-Care Diabetic & Medical Supplies, Inc. Partners with Lifescript to Provide Online Diabetes Health Center 2Health News:Med-Care Diabetic & Medical Supplies, Inc. Partners with Lifescript to Provide Online Diabetes Health Center 3Health News:Halloween at the ER Is No Treat 2Health News:Generic Drugs May Help Breast Cancer Patients Stick to Therapy 2Health News:Brain Scans Yield Clues to Chronic Fatigue Syndrome 2Health News:Brain Scans Yield Clues to Chronic Fatigue Syndrome 3
(Date:10/31/2014)... Investor-Edge has initiated coverage on the following equities: ... ABT ), Hologic Inc. (NASDAQ: HOLX ... PLC (NYSE: COV). Free research on these five companies can ... markets on Thursday, October 30, 2014, ended on a positive ... up 1.30% and the NASDAQ Composite closed at 4,566.14, up ...
(Date:10/31/2014)...  Zebra Imaging, Inc., the world,s foremost provider ... strategic partnership with the Zygote Media Group Inc., ... biomedical models for animation and visual effects, to ... maintains the world,s most comprehensive library of accurate ... development of high-end solid 3D anatomy models for ...
(Date:10/31/2014)... , Oct. 31, 2014  Australian biopharmaceutical company Specialised ... (nanoparticle albumin-bound paclitaxel) in combination with gemcitabine, will ... patients with metastatic pancreatic cancer from 1 November. ... cancer is the 5 th most common cause ... all cancer deaths, with the lowest 5-year survival of ...
Breaking Medicine Technology:Health Care Equipment Stocks Technical Insight - Medtronic, Abbott Laboratories, Hologic, ResMed, and Covidien 2Health Care Equipment Stocks Technical Insight - Medtronic, Abbott Laboratories, Hologic, ResMed, and Covidien 3Health Care Equipment Stocks Technical Insight - Medtronic, Abbott Laboratories, Hologic, ResMed, and Covidien 4Health Care Equipment Stocks Technical Insight - Medtronic, Abbott Laboratories, Hologic, ResMed, and Covidien 5Zebra Imaging and Zygote Media Partner to Bring 3D Visualization to the Medical Community 2Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 2Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 3Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 4Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 5Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 6Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 7Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 8
Cached News: